Skip to main content

Peer Review reports

From: Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

Original Submission
22 Dec 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Jan 2015 Editorially accepted
19 Feb 2015 Article published 10.1186/s12885-015-1064-9

You can find further information about peer review here.

Back to article page